Interactions between pulmonary surfactant and alveolar macrophages in the pathogenesis of lung disease

M Yoshida1, J A Whitsett

  • 1Department of Molecular Medicine, Graduate School of Medicine, Osaka University, Suita City, Osaka 565-0871, Japan. hiroinosaka@hotmail.com

Insights

The pulmonary surfactant system and alveolar macrophages are key players in lung disease development. Their complex interactions influence lung immunity and disease progression in conditions like pulmonary alveolar proteinosis and infections.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cell Biology

Background:

  • The pulmonary surfactant system is crucial for lung function.
  • Alveolar macrophages are critical immune cells in the lungs.
  • Dysregulation in lung immunity contributes to various respiratory diseases.

Purpose of the Study:

  • To review the interplay between pulmonary surfactant and alveolar macrophages.
  • To explore their roles in the pathogenesis of human lung diseases.
  • To highlight the significance of these interactions in respiratory health.

Main Methods:

  • Literature review of recent scientific findings.
  • Analysis of studies on pulmonary alveolar proteinosis, infection, inflammation, and obstructive lung diseases.
  • Synthesis of evidence on the bidirectional communication between surfactant components and macrophages.

Main Results:

  • Pulmonary surfactant components modulate innate lung defense via alveolar macrophages.
  • Alveolar macrophages regulate surfactant homeostasis, including clearance and catabolism.
  • Complex interactions are intrinsically linked to the development of diverse lung pathologies.

Conclusions:

  • The reciprocal relationship between surfactant and macrophages is fundamental to lung homeostasis.
  • Disruptions in this interaction are implicated in the pathogenesis of multiple lung diseases.
  • Further research into this interplay may reveal novel therapeutic targets for respiratory conditions.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Alveoli and Alveolar Ducts01:26

Alveoli and Alveolar Ducts

The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.